EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review
{{output}}
Advances in molecular biology have positioned epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) as highly effective therapies for patients with EGFR-mutant carcinomas. However, the inevitable emergence of acquired resistance significantly... ...
